Intravenous Infusions

Most recent documents

Year Type Description Download
2021 Annual Report Audited Financial Statements for the Full Year (12 Months) Ended December 2021
2020 Annual Report Audited Financial Statements for the Full Year (12 Months) Ended December 2020
2022 Interim Statement Unaudited Financials for the Half Year (6 Months) Ended June 2022
2021 Interim Statement Unaudited Financials for the Half Year (6 Months) Ended June 2021
2020 Interim Statement Unaudited Financials for the Half Year (6 Months) Ended June 2020
2022 Corporate Action INTRAVENOUS INFUSION PLC NOTICE OF ANNUAL GENERAL MEETING
2022 Corporate Action INTRAVENOUS INFUSION AUDITED FINANCIAL STATEMENTS FOR THE FULL YEAR (12 MONTHS) ENDED DECEMBER 2021
2022 Corporate Action NOTICE OF EXTENSION OF TIME FOR THE SUBMISSION OF AUDITED FINANCIAL STATEMENTS FOR YEAR ENDED DECEMBER 2021
2021 Corporate Action Intravenous Infusions (Facts behind the Figures, September 2021)
2021 Corporate Action DIVIDEND PAYMENT (2020)
2021 Corporate Action NTRAVENOUS ANNUAL REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 2020
2020 Corporate Action Appointment of Managing Director and General Manager Technical and Operations
2020 Corporate Action Notification Appointment of Intellisys Chartered Accountants as Auditors
2020 Corporate Action Notification of Approved Dividend for 2019 and Appointment of Intellisys (Chartered Accountants) as External Auditor
2020 Corporate Action Notice of Virtual Annual General Meeting
2020 Corporate Action Final Dividend, Closure of Register
2020 Corporate Action Notice of Virtual Annual General Meeting
2020 Corporate Action Notification of Resignation of Managing Director
2020 Corporate Action Audited Report and Financial Statements for the Full Year Ended December 2019 (Full)

Archived documents

Year Type Description Download
2019 Annual Report 2019 Annual Report and Financial Statements (Complete)
2018 Annual Report 2018 Annual Report and Financial Statements (Complete)
2017 Annual Report 2017 Annual Report and Financial Statements (Complete)
2016 Annual Report 2016 Annual Report and Financial Statements (Complete)
2015 Annual Report 2015 Annual Report and Financial Statements (Complete)
2019 Interim Statement Unaudited Financials for the Half Year (6 Months) Ended June 2019
2018 Interim Statement Unaudited Financials for the Half Year (6 Months) Ended June 2018
2017 Interim Statement Unaudited Financials for the Half Year (6 Months) Ended June 2017
2016 Interim Statement Unaudited Financials for the Nine Months (Including Third Quarter) Ended September 2016
2016 Interim Statement Unaudited Financials for the Half Year (Six Months) Ended June 2016
2015 Prospectus IPO Prospectus
2019 Corporate Action Notice of Annual General Meeting - Intravenous Infusions
2019 Corporate Action Final Dividend and Book Closure
2019 Corporate Action Audited Financial Statements for Full Year (12 Months) Ended December 2018
2019 Corporate Action Results of Private Placement Offer
2018 Corporate Action Appointment of a Director
2018 Corporate Action Notice of Annual General Meeting - Intravenous Infusions
2018 Corporate Action Audited Financial Statements for Full Year (12 Months) Ended December 2017
2018 Corporate Action Notification of Change in Registered Office Address
2017 Corporate Action Notice of Annual General Meeting - Intravenous Infusions
2017 Corporate Action GSE Facts Behind the Figures Presentation
2017 Corporate Action Audited Financial Statements for Full Year (12 Months) Ended December 2016
2017 Corporate Action Change in Managing Director
2017 Corporate Action New Managing Director and General Manager
2016 Corporate Action Notice of Annual General Meeting - Intravenous Infusions
2016 Corporate Action Audited Financial Statements for Full Year (12 Months) Ended December 2015
2016 Corporate Action Audited Financial Statements for Full Year (12 Months) Ended December 2015
2015 Corporate Action IPO Results
2015 Corporate Action IPO Temporarily Put on Hold